‘Endless RNA’ startup Laronde raises $440m to fuel pipelineJust a few months after breaking cover with its new take on RNA therapeutics, Laronde has raised an Share X‘Endless RNA’ startup Laronde raises $440m to fuel pipelinehttps://pharmaphorum.com/news/endless-rna-startup-laronde-raises-440m-to-fuel-pipeline/
Moderna’s founder launches Laronde, promising new ‘Endless RNA’ drug classFlagship Pioneering, the VC fund run by Moderna’s co-founder Noubar Afeyan has launched a new biotech Laronde, with Share XModerna’s founder launches Laronde, promising new ‘Endless RNA’ drug classhttps://pharmaphorum.com/news/modernas-co-founder-launches-laronde-promising-new-endless-rna-drug-class/
Rethinking drug discoveryGeorge Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change. Share XRethinking drug discoveryhttps://pharmaphorum.com/r-d/views-analysis-r-d/rethinking-drug-discovery/
